$AVM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMAG PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMAG PHARMACEUTICALS, INC.. Get notifications about new insider transactions in AMAG PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 11 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, Chief Operatin ... | Grant | A | 0.00 | 12,500 | 0 | 40,800 | 28.3 K to 40.8 K (+44.17 %) |
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, Chief Operatin ... | Grant | A | 0.00 | 6,300 | 0 | 28,300 | 22 K to 28.3 K (+28.64 %) |
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Option Exercise | A | 16.55 | 30,000 | 496,500 | 30,000 | |
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Grant | A | 0.00 | 10,000 | 0 | 15,000 | 5 K to 15 K (+200.00 %) |
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | Townsend Scott B | SVP, General Counse ... | Option Exercise | A | 16.55 | 26,300 | 435,265 | 26,300 | |
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | Townsend Scott B | SVP, General Counse ... | Grant | A | 0.00 | 7,500 | 0 | 11,900 | 4.4 K to 11.9 K (+170.45 %) |
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | Townsend Scott B | SVP, General Counse ... | Grant | A | 0.00 | 4,400 | 0 | 4,400 | 0 to 4.4 K |
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | Holmes Scott A | VP, Chief Accountin ... | Option Exercise | A | 16.55 | 15,000 | 248,250 | 15,000 | |
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | Holmes Scott A | VP, Chief Accountin ... | Grant | A | 0.00 | 5,000 | 0 | 7,500 | 2.5 K to 7.5 K (+200.00 %) |
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | Holmes Scott A | VP, Chief Accountin ... | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | Madison Greg | EVP, Chief Commerci ... | Option Exercise | A | 16.55 | 37,500 | 620,625 | 37,500 | |
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | Madison Greg | EVP, Chief Commerci ... | Grant | A | 0.00 | 12,500 | 0 | 18,800 | 6.3 K to 18.8 K (+198.41 %) |
| Mar 04 2013 | AVM | AMAG PHARMACEUTICA ... | Madison Greg | EVP, Chief Commerci ... | Grant | A | 0.00 | 6,300 | 0 | 6,300 | 0 to 6.3 K |
| Feb 26 2013 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Option Exercise | M | 0.00 | 833 | 0 | 834 | |
| Feb 26 2013 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Sell | S | 16.37 | 400 | 6,548 | 0 | 400 to 0 (-100.00 %) |
| Feb 26 2013 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Sell | S | 16.39 | 433 | 7,097 | 400 | 833 to 400 (-51.98 %) |
| Feb 26 2013 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Buy | M | 0.00 | 833 | 0 | 833 | 0 to 833 |
| Jan 09 2013 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Option Exercise | M | 0.00 | 4,000 | 0 | 4,000 | |
| Jan 09 2013 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Sell | S | 15.80 | 3,000 | 47,407 | 0 | 3 K to 0 (-100.00 %) |
| Jan 09 2013 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Sell | S | 15.87 | 3,000 | 47,600 | 3,000 | 6 K to 3 K (-50.00 %) |
| Jan 09 2013 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Buy | M | 0.00 | 4,000 | 0 | 6,000 | 2 K to 6 K (+200.00 %) |
| Jan 09 2013 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Sell | S | 16.07 | 4,000 | 64,285 | 2,000 | 6 K to 2 K (-66.67 %) |
| Jan 07 2013 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
| Jan 07 2013 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Sell | S | 16.03 | 4,000 | 64,102 | 6,000 | 10 K to 6 K (-40.00 %) |
| Jan 07 2013 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Buy | M | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Jan 04 2013 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, COO | Option Exercise | M | 0.00 | 20,000 | 0 | 20,000 | |
| Jan 04 2013 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, COO | Sell | S | 15.60 | 10,000 | 155,969 | 22,000 | 32 K to 22 K (-31.25 %) |
| Jan 04 2013 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, COO | Buy | M | 0.00 | 20,000 | 0 | 32,000 | 12 K to 32 K (+166.67 %) |
| Jan 03 2013 | AVM | AMAG PHARMACEUTICA ... | Madison Greg | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
| Jan 03 2013 | AVM | AMAG PHARMACEUTICA ... | Madison Greg | EVP, Chief Commerci ... | Option Exercise | A | 15.89 | 75,000 | 1,191,750 | 75,000 | |
| Dec 06 2012 | AVM | AMAG PHARMACEUTICA ... | Holmes Scott A | Chief Accounting Of ... | Option Exercise | M | 0.00 | 2,500 | 0 | 2,500 | |
| Dec 06 2012 | AVM | AMAG PHARMACEUTICA ... | Holmes Scott A | Chief Accounting Of ... | Sell | S | 14.79 | 2,500 | 36,975 | 0 | 2.5 K to 0 (-100.00 %) |
| Dec 06 2012 | AVM | AMAG PHARMACEUTICA ... | Holmes Scott A | Chief Accounting Of ... | Buy | M | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Dec 04 2012 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, COO | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
| Dec 04 2012 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, COO | Sell | S | 15.08 | 5,000 | 75,400 | 12,000 | 17 K to 12 K (-29.41 %) |
| Dec 04 2012 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, COO | Buy | M | 0.00 | 10,000 | 0 | 17,000 | 7 K to 17 K (+142.86 %) |
| Sep 13 2012 | AVM | AMAG PHARMACEUTICA ... | Holmes Scott A | Chief Accounting Of ... | Option Exercise | C | 0.00 | 750 | 0 | 750 | |
| Sep 13 2012 | AVM | AMAG PHARMACEUTICA ... | Holmes Scott A | Chief Accounting Of ... | Sell | S | 15.54 | 750 | 11,655 | 0 | 750 to 0 (-100.00 %) |
| Sep 13 2012 | AVM | AMAG PHARMACEUTICA ... | Holmes Scott A | Chief Accounting Of ... | Buy | C | 0.00 | 750 | 0 | 750 | 0 to 750 |
| Aug 07 2012 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP, Chief Medical ... | Option Exercise | C | 0.00 | 5,000 | 0 | 5,000 | |
| Aug 07 2012 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP, Chief Medical ... | Buy | S | 0.00 | 5,000 | 0 | 2,229 | -2,771 to 2.2 K (-180.44 %) |
| Aug 07 2012 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP, Chief Medical ... | Buy | C | 0.00 | 5,000 | 0 | 7,229 | 2.2 K to 7.2 K (+224.32 %) |
| Aug 07 2012 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Option Exercise | C | 0.00 | 3,750 | 0 | 3,750 | |
| Aug 07 2012 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Sell | S | 14.29 | 3,750 | 53,588 | 0 | 3.8 K to 0 (-100.00 %) |
| Aug 07 2012 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Buy | C | 0.00 | 3,750 | 0 | 3,750 | 0 to 3.8 K |
| Aug 03 2012 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, COO | Option Exercise | C | 0.00 | 5,000 | 0 | 15,000 | |
| Aug 03 2012 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, COO | Buy | C | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Jun 27 2012 | AVM | AMAG PHARMACEUTICA ... | Holmes Scott A | Chief Accounting Of ... | Option Exercise | A | 14.89 | 30,000 | 446,700 | 30,000 | |
| Jun 27 2012 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP, Chief Medical ... | Option Exercise | A | 14.89 | 40,000 | 595,600 | 40,000 | |
| Jun 27 2012 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Option Exercise | A | 14.89 | 40,000 | 595,600 | 40,000 | |
| May 31 2012 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP, Chief Medical ... | Option Exercise | C | 0.00 | 12,500 | 0 | 12,500 | |
| May 31 2012 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP, Chief Medical ... | Option Exercise | C | 0.00 | 1,354 | 0 | 1,354 | |
| May 31 2012 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP, Chief Medical ... | Sell | S | 0.00 | 12,500 | 0 | 2,229 | 14.7 K to 2.2 K (-84.87 %) |
| May 31 2012 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP, Chief Medical ... | Buy | C | 0.00 | 12,500 | 0 | 14,729 | 2.2 K to 14.7 K (+560.79 %) |
| May 31 2012 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP, Chief Medical ... | Sell | S | 0.00 | 1,354 | 0 | 2,229 | 3.6 K to 2.2 K (-37.79 %) |
| May 31 2012 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP, Chief Medical ... | Buy | C | 0.00 | 1,354 | 0 | 3,583 | 2.2 K to 3.6 K (+60.74 %) |
| May 29 2012 | AVM | AMAG PHARMACEUTICA ... | NARACHI MICHAEL | Director | Buy | P | 0.00 | 5,500 | 0 | 7,500 | 2 K to 7.5 K (+275.00 %) |
| May 29 2012 | AVM | AMAG PHARMACEUTICA ... | NARACHI MICHAEL | Director | Buy | P | 13.55 | 2,000 | 27,102 | 2,000 | 0 to 2 K |
| May 29 2012 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President and CEO | Buy | P | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| May 29 2012 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President and CEO | Buy | P | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| May 29 2012 | AVM | AMAG PHARMACEUTICA ... | DE SILVA RAJIV | Director | Buy | P | 0.00 | 14,822 | 0 | 14,822 | 0 to 14.8 K |
| May 25 2012 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | A | 0.00 | 2,300 | 0 | 2,300 | |
| May 25 2012 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | A | 13.30 | 3,800 | 50,540 | 3,800 | |
| May 25 2012 | AVM | AMAG PHARMACEUTICA ... | DE SILVA RAJIV | Director | Option Exercise | A | 0.00 | 2,300 | 0 | 2,300 | |
| May 25 2012 | AVM | AMAG PHARMACEUTICA ... | DE SILVA RAJIV | Director | Option Exercise | A | 13.30 | 3,800 | 50,540 | 3,800 | |
| May 25 2012 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | A | 0.00 | 2,300 | 0 | 2,300 | |
| May 25 2012 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | A | 13.30 | 3,800 | 50,540 | 3,800 | |
| May 25 2012 | AVM | AMAG PHARMACEUTICA ... | NARACHI MICHAEL | Director | Option Exercise | A | 0.00 | 3,800 | 0 | 3,800 | |
| May 25 2012 | AVM | AMAG PHARMACEUTICA ... | NARACHI MICHAEL | Director | Option Exercise | A | 13.30 | 7,600 | 101,080 | 7,600 | |
| May 25 2012 | AVM | AMAG PHARMACEUTICA ... | PEREZ ROBERT J | Director | Option Exercise | A | 0.00 | 1,900 | 0 | 1,900 | |
| May 25 2012 | AVM | AMAG PHARMACEUTICA ... | PEREZ ROBERT J | Director | Option Exercise | A | 13.30 | 3,800 | 50,540 | 3,800 | |
| May 25 2012 | AVM | AMAG PHARMACEUTICA ... | Bonventre Joseph Vincent | Director | Option Exercise | A | 0.00 | 1,900 | 0 | 1,900 | |
| May 25 2012 | AVM | AMAG PHARMACEUTICA ... | Bonventre Joseph Vincent | Director | Option Exercise | A | 13.30 | 3,800 | 50,540 | 3,800 | |
| May 25 2012 | AVM | AMAG PHARMACEUTICA ... | Russell Lesley | Director | Option Exercise | A | 0.00 | 1,900 | 0 | 1,900 | |
| May 25 2012 | AVM | AMAG PHARMACEUTICA ... | Russell Lesley | Director | Option Exercise | A | 13.30 | 3,800 | 50,540 | 3,800 | |
| May 16 2012 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
| May 16 2012 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Option Exercise | A | 12.99 | 300,000 | 3,897,000 | 300,000 | |
| Apr 02 2012 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | COO, Interim Presid ... | Buy | P | 15.86 | 500 | 7,930 | 2,000 | 1.5 K to 2 K (+33.33 %) |
| Mar 05 2012 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 15.55 | 364,387 | 5,666,218 | 4,088,296 | 3.7 M to 4.1 M (+9.79 %) |
| Mar 02 2012 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | COO, Interim CEO an ... | Buy | P | 15.81 | 500 | 7,905 | 1,500 | 1,000 to 1.5 K (+50.00 %) |
| Mar 05 2012 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 15.97 | 47,034 | 751,133 | 4,135,330 | 4.1 M to 4.1 M (+1.15 %) |
| Feb 24 2012 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | General Counsel, SV ... | Option Exercise | C | 0.00 | 833 | 0 | 833 | |
| Feb 24 2012 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | General Counsel, SV ... | Sell | S | 15.82 | 833 | 13,178 | 0 | 833 to 0 (-100.00 %) |
| Feb 24 2012 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | General Counsel, SV ... | Buy | C | 0.00 | 833 | 0 | 833 | 0 to 833 |
| Feb 24 2012 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Option Exercise | C | 0.00 | 833 | 0 | 833 | |
| Feb 24 2012 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Sell | S | 15.82 | 833 | 13,178 | 0 | 833 to 0 (-100.00 %) |
| Feb 24 2012 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Buy | C | 0.00 | 833 | 0 | 833 | 0 to 833 |
| Feb 07 2012 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | A | 0.00 | 475 | 0 | 475 | |
| Feb 07 2012 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | A | 17.25 | 950 | 16,388 | 950 | |
| Feb 07 2012 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | A | 17.25 | 6,000 | 103,500 | 6,000 | |
| Feb 07 2012 | AVM | AMAG PHARMACEUTICA ... | DE SILVA RAJIV | Director | Option Exercise | A | 0.00 | 475 | 0 | 475 | |
| Feb 07 2012 | AVM | AMAG PHARMACEUTICA ... | DE SILVA RAJIV | Director | Option Exercise | A | 17.25 | 950 | 16,388 | 950 | |
| Feb 07 2012 | AVM | AMAG PHARMACEUTICA ... | DE SILVA RAJIV | Director | Option Exercise | A | 17.25 | 6,000 | 103,500 | 6,000 | |
| Feb 02 2012 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | COO, Interim CEO an ... | Buy | P | 16.56 | 500 | 8,280 | 1,000 | 500 to 1,000 (+100.00 %) |
| Jan 10 2012 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Option Exercise | C | 0.00 | 8,000 | 0 | 8,000 | |
| Jan 10 2012 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Sell | S | 17.09 | 8,000 | 136,702 | 0 | 8 K to 0 (-100.00 %) |
| Jan 10 2012 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Buy | C | 0.00 | 8,000 | 0 | 8,000 | 0 to 8 K |
| Jan 04 2012 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP, Chief Medical ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Jan 10 2012 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | SVP, General Counse ... | Option Exercise | C | 0.00 | 8,000 | 0 | 8,000 | |
| Jan 10 2012 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | SVP, General Counse ... | Sell | S | 19.09 | 8,000 | 152,739 | 0 | 8 K to 0 (-100.00 %) |
| Jan 10 2012 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | SVP, General Counse ... | Buy | C | 0.00 | 8,000 | 0 | 8,000 | 0 to 8 K |
| Jan 04 2012 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | SVP, General Counse ... | Option Exercise | P | 0.00 | 20,000 | 0 | 20,000 | |
| Jan 04 2012 | AVM | AMAG PHARMACEUTICA ... | White Christopher G | Chief Business Offi ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Jan 04 2012 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | CFO, COO, Interim C ... | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
| Jan 04 2012 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | CFO, COO, Interim C ... | Buy | P | 19.10 | 500 | 9,550 | 500 | 0 to 500 |
| Dec 16 2011 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Buy | D | 18.38 | 5,577 | 102,484 | 2,229 | -3,348 to 2.2 K (-166.58 %) |
| Dec 02 2011 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Buy | P | 15.13 | 242 | 3,661 | 7,806 | 7.6 K to 7.8 K (+3.20 %) |
| Dec 02 2011 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | CFO, COO, Interim C ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Aug 08 2011 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | SVP, General Counse ... | Option Exercise | C | 0.00 | 2,500 | 0 | 2,500 | |
| Aug 08 2011 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | SVP, General Counse ... | Sell | S | 15.71 | 2,500 | 39,275 | 0 | 2.5 K to 0 (-100.00 %) |
| Aug 08 2011 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | SVP, General Counse ... | Buy | C | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Aug 12 2011 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Option Exercise | C | 0.00 | 5,000 | 0 | 6,250 | |
| Aug 12 2011 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Option Exercise | C | 0.00 | 1,250 | 0 | 1,250 | |
| Aug 12 2011 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Sell | S | 15.04 | 1,959 | 29,463 | 7,564 | 9.5 K to 7.6 K (-20.57 %) |
| Aug 12 2011 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Buy | C | 0.00 | 5,000 | 0 | 9,523 | 4.5 K to 9.5 K (+110.55 %) |
| Aug 12 2011 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Buy | C | 0.00 | 1,250 | 0 | 4,523 | 3.3 K to 4.5 K (+38.19 %) |
| Aug 01 2011 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Aug 01 2011 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, Chief Financia ... | Option Exercise | A | 14.91 | 60,000 | 894,600 | 60,000 | |
| Jul 29 2011 | AVM | AMAG PHARMACEUTICA ... | Zieziula Gary J | EVP, Chief Commerci ... | Option Exercise | C | 0.00 | 2,500 | 0 | 7,500 | |
| Jul 29 2011 | AVM | AMAG PHARMACEUTICA ... | Zieziula Gary J | EVP, Chief Commerci ... | Buy | C | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Jun 01 2011 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Buy | P | 13.23 | 1,322 | 17,490 | 3,273 | 2 K to 3.3 K (+67.76 %) |
| Jun 01 2011 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, CFO and CBO | Buy | P | 13.23 | 1,500 | 19,845 | 1,806 | 306 to 1.8 K (+490.20 %) |
| May 25 2011 | AVM | AMAG PHARMACEUTICA ... | ZWANZIGER RON | Director | Option Exercise | A | 0.00 | 1,900 | 0 | 1,900 | |
| May 25 2011 | AVM | AMAG PHARMACEUTICA ... | ZWANZIGER RON | Director | Option Exercise | A | 15.41 | 3,800 | 58,558 | 3,800 | |
| May 25 2011 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | A | 0.00 | 1,900 | 0 | 1,900 | |
| May 25 2011 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | A | 15.41 | 3,800 | 58,558 | 3,800 | |
| May 25 2011 | AVM | AMAG PHARMACEUTICA ... | PEREZ ROBERT J | Director | Option Exercise | A | 0.00 | 1,900 | 0 | 1,900 | |
| May 25 2011 | AVM | AMAG PHARMACEUTICA ... | PEREZ ROBERT J | Director | Option Exercise | A | 15.41 | 3,800 | 58,558 | 3,800 | |
| May 25 2011 | AVM | AMAG PHARMACEUTICA ... | Russell Lesley | Director | Option Exercise | A | 0.00 | 1,900 | 0 | 1,900 | |
| May 25 2011 | AVM | AMAG PHARMACEUTICA ... | Russell Lesley | Director | Option Exercise | A | 15.41 | 3,800 | 58,558 | 3,800 | |
| May 25 2011 | AVM | AMAG PHARMACEUTICA ... | NARACHI MICHAEL | Director | Option Exercise | A | 0.00 | 3,800 | 0 | 3,800 | |
| May 25 2011 | AVM | AMAG PHARMACEUTICA ... | NARACHI MICHAEL | Director | Option Exercise | A | 15.41 | 7,600 | 117,116 | 7,600 | |
| May 25 2011 | AVM | AMAG PHARMACEUTICA ... | Bonventre Joseph Vincent | Director | Option Exercise | A | 0.00 | 1,900 | 0 | 1,900 | |
| May 25 2011 | AVM | AMAG PHARMACEUTICA ... | Bonventre Joseph Vincent | Director | Option Exercise | A | 15.41 | 3,800 | 58,558 | 3,800 | |
| Mar 02 2011 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Option Exercise | C | 0.00 | 3,958 | 0 | 3,958 | |
| Mar 02 2011 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Sell | S | 0.00 | 3,958 | 0 | 5,000 | 9 K to 5 K (-44.18 %) |
| Mar 02 2011 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Buy | C | 0.00 | 3,958 | 0 | 8,958 | 5 K to 9 K (+79.16 %) |
| Mar 02 2011 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP, Chief Medical ... | Option Exercise | C | 0.00 | 1,354 | 0 | 1,354 | |
| Mar 02 2011 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP, Chief Medical ... | Sell | S | 0.00 | 1,354 | 0 | 0 | 1.4 K to 0 (-100.00 %) |
| Mar 02 2011 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP, Chief Medical ... | Buy | C | 0.00 | 1,354 | 0 | 1,354 | 0 to 1.4 K |
| Feb 28 2011 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, Chief Financia ... | Option Exercise | C | 0.00 | 1,875 | 0 | 1,875 | |
| Feb 28 2011 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, Chief Financia ... | Sell | S | 17.06 | 2,205 | 37,617 | 306 | 2.5 K to 306 (-87.81 %) |
| Feb 28 2011 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, Chief Financia ... | Sell | S | 17.10 | 500 | 8,550 | 2,511 | 3 K to 2.5 K (-16.61 %) |
| Feb 28 2011 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, Chief Financia ... | Buy | C | 0.00 | 1,875 | 0 | 3,011 | 1.1 K to 3 K (+165.05 %) |
| Feb 28 2011 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | SVP, General Counse ... | Option Exercise | C | 0.00 | 833 | 0 | 833 | |
| Feb 28 2011 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | SVP, General Counse ... | Sell | S | 17.10 | 833 | 14,244 | 0 | 833 to 0 (-100.00 %) |
| Feb 28 2011 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | SVP, General Counse ... | Buy | C | 0.00 | 833 | 0 | 833 | 0 to 833 |
| Jan 11 2011 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Option Exercise | A | 0.00 | 125,000 | 0 | 125,000 | |
| Jan 11 2011 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Option Exercise | A | 0.00 | 75,000 | 0 | 75,000 |